Code Sets
0 code page views
remaining today. Guest accounts are limited to 2 daily page views.
Register free account
to get more views.
Log in
Register free account
HCPCS
Temporary Procedures & Professional Services
Quality Reporting Codes
Measure Groups for Quality Payment Progr...
Measure Groups for Quality Payment Program
Measures 400-499
G8633-G9457
Measures 300-399
G9341-G9757
Measure 404: Anesthesiology Smoking Abstinence
G9497-G9645
Measure 411: Depression Remission at Six Months
G9511-G9511
Measure 415: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older
G9529-G9533
Measure 419: Overuse Of Neuroimaging For Patients With Primary Headache And A Normal Neurological Examination
G9537-G9537
Measure 421: Appropriate Assessment of Retrievable Inferior Vena Cava (IVC) Filters for Removal
G9539-G9544
Measure 406: Appropriate Follow-up Imaging for Incidental Thyroid Nodules in Patients
G9552-G9556
Measure 413: Door to Puncture Time for Endovascular Stroke Treatment
G9580-G9767
Measure 416: Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 2 Through 17 Years
G9593-G9597
Measure 420: Varicose Vein Treatment with Saphenous Ablation: Outcome Survey
G9603-G9605
Measure 422: Performing Cystoscopy at the Time of Hysterectomy for Pelvic Organ Prolapse to Detect Lower Urinary Tract Injury
G9606-G9608
Measure 423: Perioperative Anti-platelet Therapy for Patients Undergoing Carotid Endarterectomy
G9609-G9611
Measure 431: Preventive Care and Screening: Unhealthy Alcohol Use: Screening & Brief Counseling
G9621-G9624
Measure 432: Proportion of Patients Sustaining a Bladder Injury at the Time of any Pelvic Organ Prolapse Repair
G9625-G9627
Measure 433: Proportion of Patients Sustaining a Bowel Injury at the time of any Pelvic Organ Prolapse Repair
G9628-G9630
Measure 436: Radiation Consideration for Adult CT: Utilization of Dose Lowering Techniques
G9637-G9638
Measure 409: Clinical Outcome Post Endovascular Stroke Treatment
G9646-G9648
Measure 410: Psoriasis: Clinical Response to Oral Systemic or Biologic Medications
G9649-G9765
Measure 424: Perioperative Temperature Management
G9654-G9773
Measure 426: Post-Anesthetic Transfer of Care Measure: Procedure Room to a Post Anesthesia Care Unit (PACU)
G9655-G9658
Measure 439: Age Appropriate Screening Colonoscopy
G9659-G9661
Measure 438: Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
G9662-G9782
Measure 414: Evaluation or Interview for Risk of Opioid Misuse
G9683-G9685
Measure 430: Prevention of Post-Operative Nausea and Vomiting (PONV) – Combination Therapy
G9775-G9777
Measure 440: Basal Cell Carcinoma (BCC)/Squamous Cell Carcinoma: Biopsy Reporting Time – Pathologist to Clinician
G9784-G9784
Measure 441: Ischemic Vascular Disease (IVD) All or None Outcome Measure (Optimal Control)
G9787-G9797
Measure 443: Non-Recommended Cervical Cancer Screening in Adolescent Females
G9805-G9807
Measure 445: Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG)
G9812-G9813
Measure 447: Chlamydia Screening and Follow Up
G9818-G9821
Measure 448: Appropriate Workup Prior to Endometrial Ablation
G9822-G9824
Measure 450: Trastuzumab Received By Patients With AJCC Stage I (T1c) – III And HER2 Positive Breast Cancer Receiving Adjuvant Chemotherapy
G9830-G9832
Measure 451: KRAS Gene Mutation Testing Performed for Patients with Metastatic Colorectal Cancer who receive Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibody Therapy
G9838-G9841
Measure 452: Patients with Metastatic Colorectal Cancer and KRAS Gene Mutation Spared Treatment with Anti-epidermal Growth Factor Receptor (EGFR) Monoclonal Antibodies
G9842-G9845
Measure 453: Proportion Receiving Chemotherapy in the Last 14 Days of Life
G9846-G9847
Measure 457: Proportion Admitted to Hospice for less than 3 days
G9858-G9861
Measure 459: Average Change in Back Pain following Lumbar Discectomy / Laminotomy
G9943-G9943
Measure 460: Average Change in Back Pain following Lumbar Fusion
G9946-G9946
Measure 463: Prevention of Post-Operative Vomiting (POV) - Combination Therapy (Pediatrics)
G9954-G9958
Measure 464: Otitis Media with Effusion (OME): Systemic Antimicrobials- Avoidance of Inappropriate Use
G9959-G9961
Measure 465: "Uterine Artery Embolization Technique: Documentation of Angiographic Endpoints and Interrogation of Ovarian Arteries"
G9962-G9963
Measure 466: Well-child Visits
G9964-G9965